Trials / Recruiting
RecruitingNCT06992596
UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Neuralink Corp · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves participants who have tetraparesis, tetraplegia, or a diagnosis that may lead to these conditions. The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.
Conditions
- Tetraplegia/Tetraparesis
- Quadriplegia
- Quadriplegia/Tetraplegia
- Cervical Spinal Cord Injury
- Amyotrophic Lateral Sclerosis (ALS)
- Spinal Cord Injury (Quadraplegia)
- Spinal Cord Injury
- Motor Neuron Disease
- Brain Stem Stroke
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | N1 Implant | The N1 Implant is a type of implantable brain-computer interface. |
| DEVICE | R1 Robot | The R1 Robot is a robotic electrode thread inserter that implants the N1 Implant. |
Timeline
- Start date
- 2025-05-09
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
- First posted
- 2025-05-28
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT06992596. Inclusion in this directory is not an endorsement.